Ed Ashtar

Dr. Ed Ashtar Consultant Medical Oncologist & Hematologist Triple American Board-Certified NCI / NIH

Years of Experience : 20

Nationality : USA

Languages Known : English, Arabic

Book Appointment


Dr. Ed Ashtar is one of America’s top Medical Oncology and Clinical Hematology Consultants. He is a triple American Board Certified with over 20 years of experience. He received the Diploma of Human Medicine from Aleppo University Faculty of Medicine with honors and completed a Residency in Internal Medicine at the University of Kentucky Medical Center (UKMC). He was awarded the Outstanding Resident Performance of the year 1997 and the Best Physician of the Year 1999-2000 at Whitesburg Mountain Comprehensive Health Corporation (MCHC). He eventually moved to The National Institutes of Health-NIH /National Cancer Center-NCI in Bethesda, Maryland, in 2002 and completed fellowship and clinical research in Hematology/Oncology. He became the Chief of Fellows and was awarded several honors during his fellowship, including the ASCO Foundation Merit Award in 2007. He was involved in several research trials in the US and was a co-investigator in several cancer protocols. He was a key author and co-author in several ASCO presentations and publications at NIH/NCI. Dr. Ed Ashtar eventually went to private practice in 2008. He was the Head of two big institutions: The hematology and Oncology Professional Association in Pennsylvania and Cancer Professionals of Greater Washington in Northern Virginia/Maryland. He eventually moved to Dubai in 2017 and has been practicing and providing state-of-the-art care in several hospitals and oncology centers. His areas of expertise include,  

  • Oncology  
    • Diagnosis and management of all types of solid malignancies and tumors 
    • Breast cancer 
    • Lung cancer: small cell and non-small cell lung cancer NSCLC 
    • GI cancer: esophageal, esophagogastric junction, gastric, colorectal, small bowel, anal 
    • pancreatic cancer 
    • Hepatobiliary cancer: liver, biliary, ampullary, gall bladder 
    • Neuroendocrine tumors 
    • Thyroid cancer 
    • Head and neck cancers 
    • Gynecology: ovarian, fallopian tube, primary peritoneal, uterine, vulvar, gestational trophoblastic neoplasia  
    • Urology: renal, bladder, prostate, testicular, penile 
    • Soft tissue sarcomas: all types, such as leiomyosarcoma, rhabdomyosarcoma, liposarcoma, dermato fibrosarcoma, gastrointestinal stromal tumors gist, and Kaposi sarcoma.  
    • Bone cancer: such as osteosarcoma, chondrosarcoma, Ewing sarcoma  
    • Skin: basal cell carcinoma, squamous cell carcinoma, melanoma 
    • CNS cancers 
    • Other cancers such as primary occult cancers, malignant peritoneal and pleural mesothelioma, Merkel cell carcinoma, thymoma, thymic carcinoma    
  • Hematology 
    • Leukemia: acute, such as acute myeloid leukemia AML, acute lymphoblastic leukemia ALL, and chronic, such as chronic myeloid leukemia CML, chronic lymphocytic leukemia CII, hairy cell leukemia, LGL leukemia 
    • Lymphoma: B cell lymphomas such as Hodgkin lymphoma or non-Hodgkin lymphomas: diffuse large B Cell Lymphoma DLNCL, follicular lymphoma, mantle cell lymphoma, Burkitt lymphoma, primary cutaneous lymphoma, and T-cell lymphomas 
    • Multiple myeloma 
    • Myelodysplastic syndromes 
    • Myeloproliferative neoplasms: polycythemia vera, essential thrombocythemia, myelofibrosis 
    • Anemia of all types: iron deficiency, B12 deficiency, folate deficiency  
    • Hemoglobinopathies: such as thalassemia, sickle cell disease 
    • Coagulation and bleeding disorders: deep vein thromboses, congenital or acquired hemophilia, Von Willebrand disease, HITT  
    • Platelet disorders such as idiopathic thrombocytopenic purpura (ITP)  
    • Other hematological diseases: elevated white count, decreased white count, hemochromatosis, porphyria, amyloidosis, systemic mastocytosis, Waldenstrom macroglobulinemia